Bio-Rad Laboratories BIO
NYSE BIO
$376.41 +12.15 (+3.34%)
As of: Aug 20, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) EBT Margin (QoQ) (2009 - 2026)

Bio-Rad Laboratories (BIO) EBT Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 19,977.00
Mar 31, 2026 -25,055.00
Dec 31, 2025 20,006.00
Sep 30, 2025 -12,955.00
Jun 30, 2025 4,929.00
Mar 31, 2025 15,041.00
Dec 31, 2024 -26,878.00
Sep 30, 2024 56,900.00
Jun 30, 2024 -51,678.00
Mar 31, 2024 1,751.00
Dec 31, 2023 4,120.00
Sep 30, 2023 24,198.00
Jun 30, 2023 -23,282.00
Mar 31, 2023 -13,691.00
Dec 31, 2022 17,990.00
Sep 30, 2022 14,611.00
Jun 30, 2022 44,736.00
Mar 31, 2022 -34,729.00
Dec 31, 2021 -94,894.00
Sep 30, 2021 51,073.00